Constitutive activation of STAT3 is a common feature in LC, and has also been proposed to play an important role in tumor resistance to conventional and targeted small-molecule therapies (Haura et al., 2005; Gao et al., 2007). The gene discussed is STAT3; the disease is laryngotracheoesophageal cleft.